NanoViricides, Inc. (NNVC)
1.14
-0.03
(-2.56%)
USD |
NYAM |
Nov 20, 16:00
1.14
0.00 (0.00%)
After-Hours: 20:00
NanoViricides Price to Book Value : 4.543 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 4.543 |
| November 19, 2026 | 4.662 |
| November 18, 2026 | 4.742 |
| November 17, 2026 | 4.622 |
| November 16, 2026 | 4.941 |
| November 13, 2026 | 4.901 |
| November 12, 2026 | 5.380 |
| November 11, 2026 | 5.499 |
| November 10, 2026 | 5.658 |
| November 09, 2026 | 5.300 |
| November 06, 2026 | 5.26 |
| November 05, 2026 | 5.140 |
| November 04, 2026 | 5.499 |
| November 03, 2026 | 5.698 |
| November 02, 2026 | 5.380 |
| October 30, 2026 | 5.300 |
| October 29, 2026 | 5.698 |
| October 28, 2026 | 5.778 |
| October 27, 2026 | 5.818 |
| October 26, 2026 | 5.419 |
| October 23, 2026 | 5.579 |
| October 22, 2026 | 5.539 |
| October 21, 2026 | 6.017 |
| October 20, 2026 | 5.898 |
| October 19, 2026 | 5.180 |
| Date | Value |
|---|---|
| October 16, 2026 | 5.499 |
| October 15, 2026 | 5.459 |
| October 14, 2026 | 5.220 |
| October 13, 2026 | 5.26 |
| October 12, 2026 | 5.101 |
| October 09, 2026 | 5.180 |
| October 08, 2026 | 5.220 |
| October 07, 2026 | 5.738 |
| October 06, 2026 | 5.579 |
| October 05, 2026 | 5.778 |
| October 02, 2026 | 5.101 |
| October 01, 2026 | 5.021 |
| September 30, 2026 | 5.180 |
| September 29, 2026 | 3.445 |
| September 28, 2026 | 3.975 |
| September 25, 2026 | 3.816 |
| September 24, 2026 | 3.816 |
| September 23, 2026 | 4.001 |
| September 22, 2026 | 4.054 |
| September 21, 2026 | 4.478 |
| September 18, 2026 | 3.763 |
| September 17, 2026 | 3.710 |
| September 16, 2026 | 3.180 |
| September 15, 2026 | 2.782 |
| September 14, 2026 | 2.782 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| PEG Ratio | -0.4089 |
| Price | 1.14 |
| Earnings Yield | -46.96% |
| Market Cap | 29.13M |
| PEGY Ratio | -0.4089 |